ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,585.60
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.625
      0.08%
      Bitcoin
      61,542.94
      0.58%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Heat Biologics Inc (HTBX)

      7. Heat Biologics Inc (HTBX) News

      HTBX

      Heat Biologics (HTBX)

      Heat Biologics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:HTBX
      DateTimeSourceHeadlineSymbolCompany
      1:05PMiHub NewswireFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      05/15/20234:34PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
      05/15/20234:28PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      03/31/20234:15PMEdgar (US Regulatory)Annual Report (10-k)AMEX:HTBXHeat Biologics Inc
      03/31/20234:09PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      03/23/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      03/13/20237:54AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      02/02/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      12/30/20224:06PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HTBXHeat Biologics Inc
      12/09/20225:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
      12/09/20225:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
      12/09/20224:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
      11/14/20224:54PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
      11/14/20224:46PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      09/16/20224:36PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      08/22/20227:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      08/10/20224:12PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
      08/10/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      06/06/20224:29PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:HTBXHeat Biologics Inc
      05/16/20225:25PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
      05/16/20224:44PMGlobeNewswire Inc.NightHawk Biosciences Provides First Quarter 2022 Business UpdateAMEX:HTBXHeat Biologics Inc
      05/10/20228:00AMGlobeNewswire Inc.NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35AMEX:HTBXHeat Biologics Inc
      05/03/20227:15AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      05/03/20227:00AMGlobeNewswire Inc.Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open TodayAMEX:HTBXHeat Biologics Inc
      04/27/20228:00AMGlobeNewswire Inc.Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian GovernmentAMEX:HTBXHeat Biologics Inc
      04/20/20228:08AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
      04/20/20228:00AMGlobeNewswire Inc.Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys TherapeuticsAMEX:HTBXHeat Biologics Inc
      04/19/202211:00AMGlobeNewswire Inc.Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense CapabilitiesAMEX:HTBXHeat Biologics Inc
      04/18/20224:00PMGlobeNewswire Inc.REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
      04/18/20228:30AMGlobeNewswire Inc.Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing FacilityAMEX:HTBXHeat Biologics Inc
       Showing the most relevant articles for your search:AMEX:HTBX